Law Offices of Howard G. Smith has initiated securities fraud class action lawsuits against Oracle Corporation, Paysafe Holdings, Inovio Pharmaceuticals, and Kyndryl Holdings, each facing distinct allegations of material misrepresentation to investors. Oracle is accused of making misleading statements regarding artificial intelligence infrastructure capital expenditures that were not supported by corresponding revenue growth. The litigation underscores ongoing investor scrutiny regarding the alignment between major technology investments and actual business results.
Paysafe faces claims of failing to adequately disclose exposure to high-risk clients and undisclosed issues related to merchant category code classifications. Separately, Inovio Pharmaceuticals is charged with making false statements about its manufacturing capabilities and prospects for FDA approval of its INO-3107 device. Kyndryl Holdings, meanwhile, is accused of materially misstating financial statements and maintaining inadequate internal control mechanisms over financial reporting.
Investors who sustained losses in these securities are being reminded of approaching deadlines to file lead plaintiff motions in the respective class actions. The lawsuits represent part of a broader pattern of litigation stemming from allegations of disclosure failures and financial statement inaccuracies at major publicly-traded firms. Eligible investors are encouraged to review specific deadline requirements for each case.